BioXcel Therapeutics Inc (BTAI) — Tangible Net Worth Ratio
BioXcel Therapeutics Inc (BTAI) has a Tangible Net Worth Ratio of 100.0% as of June 2023. This metric is calculated by deducting intangible assets ($0.00) from net assets ($5.86 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See BioXcel Therapeutics Inc shareholders equity for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
BioXcel Therapeutics Inc Tangible Net Worth Ratio (2018–2022)
This chart shows how BioXcel Therapeutics Inc's Tangible Net Worth Ratio has changed across 5 annual periods from 2018 to 2022. As of June 2023, the ratio stands at 100.0%, reflecting net assets of $5.86 Million with intangible assets of $0.00 USD. Also explore BioXcel Therapeutics Inc net asset momentum to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for BioXcel Therapeutics Inc (2018–2022)
The table below presents the year-by-year Tangible Net Worth Ratio for BioXcel Therapeutics Inc from 2018 to 2022, covering 5 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see how much is BioXcel Therapeutics Inc worth.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2022 | 100.0% | $76.78 Million | $0.00 | $205.85 Million | ▲ +0.0 pp |
| 2021 | 100.0% | $221.67 Million | $0.00 | $239.44 Million | ▲ +0.0 pp |
| 2020 | 100.0% | $206.70 Million | $0.00 | $219.94 Million | ▲ +0.0 pp |
| 2019 | 100.0% | $26.89 Million | $0.00 | $36.39 Million | ▲ +0.0 pp |
| 2018 | 100.0% | $38.89 Million | $0.00 | $43.55 Million | — |